Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

SC refuses relief to Roche on patent plea against Cipla
The Supreme Court today refused to give any relief to Swiss pharma firm Hoffman La Roche Ltd that had challenged a Delhi High Court order allowing Cipla to manufacture and sell a generic version of lung cancer drug "Erlotinib".

Amitabh transfers land in UP for college named after Aishwarya
Nearly two years after Amitabh Bachchan laid the foundation of a girls college named after his daughter-in-law and actress Aishwarya Rai in Barabanki district, legal formalities have been completed to transfer the land to the organisation building it.

News of the day

Mamata dismisses Lalu Prasad's claims on Indian Railways' turnaround
Railway Minister and Trinamool Congress chief Mamata Banerjee today hit her predecessor Lalu Prasad where it hurt him most—on the supposed turnaround of Indian Railways during Prasad’s regime.
Management

Dr Reddy's Lab rises 2.3%

The stock jumped 2.3 per cent to Rs 1,204.55 after the company said Phase-III clinical trial for its anti-diabetic molecule balaglitazone achieved the set parameters. - Dr Reddy"s to strengthen domestic biz - Dr Reddy"s plans to launch Lipitor"s generic version in US - Dr Reddy"s develops generic version of Pfizer"s Lipitor - Intermediate trend reversal confirmed - DRL net doubles to Rs 217 cr - Dr Reddy"s forays into transdermal patch segment The company which conducted the study to determine the efficacy and safety of the drug, with Rheoscience — a subsidiary of Nordic Bioscience said, it met its primary endpoint of reducing HbA1c or Glycoslated haemoglobin molecule, which indicates glucose level in blood. Besides, the oral anti-diabetic drug also showed effective results on fasting plasma glucose, oedeman and weight gain & body composition.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009